Search research articles
Contact Us
Filters
Showing results (1-10 of 112) with videos related to
Page
of 12
Sort By:
Minerva Gastroenterology
|
April 15, 2021
Impact of direct antiviral agents (DAAs) on B-cell non-Hodgkin's lymphoma in patients with chronic hepatitis C
Alessia Ciancio
The Lancet. Infectious Diseases
|
July 21, 2015
The prenylation inhibitor, lonafarnib: a new therapeutic strategy against hepatitis delta
Mario Rizzetto, Alessia Ciancio
Nature Reviews. Gastroenterology & Hepatology
|
September 11, 2013
Chronic hepatitis D at a standstill: where do we go from here?
Alessia Ciancio, Mario Rizzetto
Molecular Aspects of Medicine
|
December 11, 2007
Chronic HBV-related liver disease
Mario Rizzetto, Alessia Ciancio
Nature Reviews. Gastroenterology & Hepatology
|
June 7, 2011
Hepatitis: PEG-IFN for the treatment of hepatitis D
Alessia Ciancio, Mario Rizzetto
Seminars in Liver Disease
|
August 31, 2012
Epidemiology of hepatitis D
Mario Rizzetto, Alessia Ciancio
European Journal of Gastroenterology & Hepatology
|
November 6, 2018
Delta hepatitis in resolved hepatitis B
Antonio Ponzetto, Alessia Ciancio, Natale Figura
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 24, 2019
Addition of Bismuth to the Standard Triple Therapy for Helicobacter Pylori Infection
Antonio Ponzetto, Piero Riva, Alessia Ciancio
Digestive Diseases (Basel, Switzerland)
|
May 24, 2018
Containing the Costs of Recurrent Gastro-Duodenal Ulcer Bleeding
Antonio Ponzetto, Natale Figura, Alessia Ciancio
Viruses
|
August 26, 2022
A Review of HDV Infection
Gian Paolo Caviglia, Alessia Ciancio, Mario Rizzetto
Page
of 12
Search research articles
Search
Showing results (1-10 of 112) with videos related to
Sort By:
Page
of 12
Minerva Gastroenterology
|
April 15, 2021
Impact of direct antiviral agents (DAAs) on B-cell non-Hodgkin's lymphoma in patients with chronic hepatitis C
Alessia Ciancio
The Lancet. Infectious Diseases
|
July 21, 2015
The prenylation inhibitor, lonafarnib: a new therapeutic strategy against hepatitis delta
Mario Rizzetto, Alessia Ciancio
Nature Reviews. Gastroenterology & Hepatology
|
September 11, 2013
Chronic hepatitis D at a standstill: where do we go from here?
Alessia Ciancio, Mario Rizzetto
Molecular Aspects of Medicine
|
December 11, 2007
Chronic HBV-related liver disease
Mario Rizzetto, Alessia Ciancio
Nature Reviews. Gastroenterology & Hepatology
|
June 7, 2011
Hepatitis: PEG-IFN for the treatment of hepatitis D
Alessia Ciancio, Mario Rizzetto
Seminars in Liver Disease
|
August 31, 2012
Epidemiology of hepatitis D
Mario Rizzetto, Alessia Ciancio
European Journal of Gastroenterology & Hepatology
|
November 6, 2018
Delta hepatitis in resolved hepatitis B
Antonio Ponzetto, Alessia Ciancio, Natale Figura
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 24, 2019
Addition of Bismuth to the Standard Triple Therapy for Helicobacter Pylori Infection
Antonio Ponzetto, Piero Riva, Alessia Ciancio
Digestive Diseases (Basel, Switzerland)
|
May 24, 2018
Containing the Costs of Recurrent Gastro-Duodenal Ulcer Bleeding
Antonio Ponzetto, Natale Figura, Alessia Ciancio
Viruses
|
August 26, 2022
A Review of HDV Infection
Gian Paolo Caviglia, Alessia Ciancio, Mario Rizzetto
Page
of 12